Health - Innovators
Your Science Is Breakthrough. You want it to reach the world.
How to Avoid the Go-To-Market Becoming a Nightmare?
You’ve Solved a Hard Problem. Now Comes the Harder One.
Stop wasting 18 months chasing distributors who ghost you. Connect with vetted partners across 17+ countries who understand your category and want serious long-term strategic partnerships.
Your technology works. You’ve spent 3-7 years on R&D. You’ve navigated regulatory…
…then you hit commercialization.
Questions nobody warned you about:
- Which markets first—and in what sequence?
- Direct or through distributors?
- How do we find distributors who understand our category vs. generic reps?
- What’s realistic forecasting when we’ve never sold in Brazil/Germany/Thailand?
- Hospital, clinic, DTC, or hybrid?
- How to avoid 18-month regulatory hell in every market
Your CTO says, “Just find distributors at MEDICA.”
Your CFO says, “We need revenue in 12 months, or the next round dies.”
Your investors say, “We need traction in 3 markets by Q3.”
The Distribution Death March
Month 1-3: Conference Circuit
- A booth in a reference event €10K+
- 47 “promising conversations.”
- Result: 47 cards. 2 follow-ups. 0 LOIs.
Month 4-8: Cold Outreach
- 200 emails to “healthcare distributors in Europe.”; 12 responses; 4 intro calls (tire-kickers); 1 serious conversation (wants exclusive rights to 15 countries before seeing data).
- Result: 3 months founder time. 1 lowball offer.
Month 9-12: Partnership That Goes Nowhere
- Finally sign LOI with distributor who seems legit.
Six months later:
- 3 sales calls (same hospital). They want YOU to create all materials. You need to hire translators. Discount requests are coming. Margin projection falling. Your solution is not brought to their sales training.
- Result: 9 months wasted. €20-50K support costs. €0 revenue.
Scaling your business globally shouldn’t be like driving blind!
“We started sales in Mexico after a former employee of a competitor requested distribution rights. Our team is expressing dissatisfaction with the unpredictable workload. Margins are very low… we didn’t have a plan.“
— CEO and founder of a European Personalised Medicine company.
The Real Go-to-Market Problems
A Contradictory Logic:
Need partners to show traction. Can’t validate partners without traction.
What You Actually Need
- Pre-vetted distributors with proven track records in YOUR category
- Strategic fit assessment (markets, channels, capabilities that align)
- Execution capability (partners who do market development work)
- Market intelligence (which markets to prioritize, realistic timelines)
- Investor validation (angels, VCs, or CVCs… who fund your category, seeing commercial proof)
- Peer learning (from innovators who’ve scaled in your space)
Introducing the LONGEVITY REACH PARTNERS
Who We Are:
We are a network of strategic partners collaborating to promote practical business growth opportunities and help innovations reach more people worldwide. Faster!
Join us to build your distribution ecosystem driven to long-term commercial scale
The INNOVATORS & SEED membership
Access to Vetted Distribution Partners
- 35+ established distributors across 17+ countries
- Pre-qualified for category expertise, execution, and strategic fit
- Direct introductions based on YOUR target markets
Strategic Partner Matching
Every introduction evaluates:
- Geographic alignment (your targets + their territories)
- Category expertise (your tech + their capabilities)
- Channel fit (hospital/clinic/DTC alignment)
- Stage appropriateness (your readiness + their needs)
The LONGITUTE global event
Invitation to participate in the global in-person event in October, to discuss the latest in Longevity-Driven Economy and enriching business growth opportunities.
Quarterly Strategic Meetings
(Jan 29, Apr 30, Jul 30)
- 240-360 minutes with a complete ecosystem
- Market intelligence across geographies
- Event Intelligence, such as ARRD, CES, MEDICA, CMEF China, Medtec Japan, WHX Dubai, APN Longevity
- Strategic introductions
Monthly Knowledge Sessions
- 8/year, 120 min each
- Leadership & Commercial Strategy Workshops: Systems Thinking, Talent Management, Branding, Commercial Effectiveness, Post-Sales & Service Models, Strategic Finance
- Regulatory & Market Topics: Data Privacy Laws, Targeted Regulatory Intelligence, Customer & Consumer Insights, Modern Techniques, Netnography
Market Expansion Roadmap
- Work with the ecosystem to build realistic multi-market strategies
- Understand regulatory sequencing
- Learn from peers who’ve scaled
Direct Investor Introductions
- VCs actively funding longevity
- Pitch to investors who’ve heard commercial validation from distributors
- Co-investment beyond just capital
“When looking for investors, my main questions are which investors understand women’s health and AI-driven consumer health products, who can help open the right growth channels such as insurers, health networks, or large consumer platforms, and how to quickly filter for investors at the right stage and cheque size who have experience backing B2C health solutions and can support expansion.”
— Founder of a Women’s Healthcare startup.
“9 Months in Discussions, Nothing Closing.”
— Founder of a Dermacosmetics company
Before: Endless emails, unclear timelines, no transparency
With LRP: Pre-qualified distributors and pre-aligned investors, clear feedback, partnerships close in 3-6 months vs 12-18 … savings significant time and resources in business development and fundraising
What Makes This Different
1. Strategic Relationships, Not 5-Min Pitches
The focus is not on pitch decks. Instead, you focus on the complete story and long-term relationships.
We facilitate 1-on-1 intros based on fit. Relationships are built over 12 months.
2. Pre-Vetted Both Sides
Innovators screened for regulatory status, clinical evidence, and commercial readiness.
Distributors screened for track record (with decades of experience), category expertise, and financial stability.
3. Market Intelligence, Not Just Connections
Which markets have the easiest regulatory environment? What reimbursement evidence is needed? What pricing models work? What are realistic sales ramps?
4. Investor Validation Built-In
Traditional: Pitch investors → They ask about traction → You explain “discussions” → They pass
LRP: Join ecosystem → Distributors evaluate → Some commit (validation) → Investors see proof → You pitch with evidence
5. Category-Specific
Not generic “healthtech.” Organized by 12 longevity categories—connect with distributors who understand YOUR technology.
6. Capital dilution? Perhaps it is not yet necessary
If there are still alternatives to divesting 10% or 20% of your company, we will openly discuss other options while training your team.
“We know that quality comes with a value. However, we had a bad experience paying a €4,000 retainer to agents who blindly sent 1,000 emails to the investor list. She even reached out to one of our own investor. We were ashamed!”
— Founder of a Life Support Systems Series A+ startup
Before: Either a lot of time dedicated to fundraising or investing thousands of euros in unqualified fundraising support without good returns
With LRP: Continuous high-quality fundraising discussions, long-term investment planning, while upskilling all startup teams with as low as €250 per month for Series A+ and lower for Seed and Pre-Seed stage startups
What Are The Investment & The Benefits for Joining The Longevity Reach Partners?
INNOVATORS
Established and Series A+See INNOVATORS benefits
Market Expansion, Team Upskilling & Fundraising FocusSEED
Pre-Seed & Seed Stage (Subject of Approval)See the SEED Membership Benefits
For Pre-Seed & Seed Stage StartupsMake sure to review the terms and conditions before enrollment: INNOVATORS; SEED (Pre-Seed & Seed Stage Startups)
“Just a quick note to let you know how much I enjoyed your presentation and the data you shared! Really great stuff, and selfishly, I find it exciting as it supports some work I’m doing here in the US. “
— CEO of a Personalised Nutrition startup
See The Categories We Will Explore During This Journey:
CLINICAL & INSTITUTIONAL SOLUTIONS
Cardiometabolics Health Systems: cardiovascular devices & diagnostics; metabolic health monitoring; heart health technologies; diabetes & metabolic syndrome
Neurology, Cognitive & Mental Wellness: neurology & cognitive health devices; brain health technologies; mental wellness solutions; cognitive enhancement tools
Musculoskeletal, Rehabilitation & Pain: musculoskeletal & orthopedics; rehabilitation technologies; mobility & functional health; pain management solutions
Cellular, Regenerative & Aesthetics: cellular & regenerative medicine; clinical aesthetic treatments; biologics & advanced therapies; longevity clinic technologies
Women’s & Hormonal Health: women’s & hormonal health: fertility & reproductive health; menopause management; pregnancy & maternal health
Precision Diagnostics & Biomarkers: diagnostics & biomarkers; laboratory services; genetic & genomic testing; advanced screening technologies; biological age assessment
Clinical Digital Health & Remote Monitoring: digital health & remote monitoring; telehealth platforms; clinical-grade digital therapeutics; connected care solutions
Sleep Medicine & Circadian Health: clinical sleep diagnostics; sleep disorder treatments; circadian rhythm technologies; professional sleep optimization
Hospital Acute Care & Critical Systems: hospital acute care technologies; critical care systems; surgical & interventional devices; emergency medicine solutions; intensive care technologies
CONSUMER WELLNESS CATEGORIES
Nutritional Longevity & Supplements: longevity nutrition products; OTC supplements & medicines; gut health & microbiome products; functional foods
Consumer Digital Health & Wearables: Consumer wearables & sensors; wellness software & apps; direct-to-consumer lab tests; sleep tracking & circadian health
Dermacosmetics & Aesthetic Wellness: non-prescription dermacosmetics; at-home aesthetic devices; anti-aging skincare technologies
“We do not need distributors, we need strategic partners.”
– said the EMEA IVD Divisional Vice-President of a MedTech global giant
This initiative is supported by:
